|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/18 | (2006.01) |
| A61K 9/08 | (2006.01) | ||
| A61K 9/19 | (2006.01) | ||
| A61P 25/00 | (2006.01) |
| (11) | Number of the document | 3287140 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16782601.5 |
| Date of filing the European patent application | 2016-04-18 | |
| (97) | Date of publication of the European application | 2018-02-28 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2016/079571 |
| Date | 2016-04-18 |
| (87) | Number | WO 2016/169454 |
| Date | 2016-10-27 |
| (30) | Number | Date | Country code |
| 201510189156 | 2015-04-21 | CN |
| (72) |
TAN, Jianping , CN
WANG, Bingzhang , CN
|
| (73) |
Staidson (Beijing) Biopharmaceuticals Co., Ltd. ,
No.36 Jinghai Er Road BDA, Beijing 100176,
CN
Beijing Staidson Medical Technology Co., Ltd. , Room 501,Building 5, No.36 Jinghai Er Road, BDA, Beijing 100176, CN |
| (54) | NERVE GROWTH FACTOR COMPOSITION AND POWDER INJECTION |
| NERVE GROWTH FACTOR COMPOSITION AND POWDER INJECTION |